Aerin Medical Secures $32.5M to Fuel Growth in ENT Treatments
Deal News | Jan 13, 2025 | Questa Capital Management LLC
Aerin Medical, a venture-backed medical device company specializing in treatments for chronic ENT conditions, has successfully secured $32.5 million in equity capital from a consortium of investors comprising KCK MedTech, Questa Capital, OrbiMed, Ally Bridge Group, and new participant Ares Capital. The capital injection aims to bolster Aerin Medical's commercial expansion, research and development endeavors, and clinical evidence generation. Alongside the equity funding, Aerin has also secured a debt facility from Ares Capital, which will enable the refinancing of existing debt and provide the company with enhanced financial flexibility. This strategic funding empowers Aerin Medical to continue its mission of improving patient outcomes through innovative, less invasive medical technologies, including its VivAer and RhinAer products.
Sectors
- Medical Devices
- Venture Capital
Geography
- United States – Aerin Medical is headquartered in Mountain View, California, and the investment firms involved are based in the United States, indicating the geographical focus of this transaction.
Industry
- Medical Devices – Aerin Medical operates within the medical devices sector, offering products that address chronic ENT conditions using innovative technology.
- Venture Capital – Aerin Medical's funding round involves participation from venture capital firms, reflecting the role of VC in financing the medical technology advancements.
Financials
- $32.5 million – The total amount of new equity capital raised by Aerin Medical in its recent funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Aerin Medical | Target Company | Company | A privately held medical device company focusing on non-surgical treatments for chronic ENT conditions. |
| Questa Capital Management LLC | Investor | Company | A private equity firm participating as an existing investor in Aerin Medical's funding round. |
| KCK MedTech | Investor | Company | An existing investor in Aerin Medical contributing to the $32.5 million funding round. |
| OrbiMed | Investor | Company | An existing investor involved in the latest equity financing for Aerin Medical. |
| Ally Bridge Group | Investor | Company | A participant in Aerin Medical's recent funding round, providing capital to support growth efforts. |
| Ares Capital | New Investor & Debt Provider | Company | A new participant in the equity round and provider of debt facility to Aerin Medical for refinancing purposes. |
| Matt Brokaw | CEO | Person | The CEO of Aerin Medical responsible for leading the company's growth and strategic initiatives. |